Table 1.
Clinical factors of the training, validation, and testing cohorts. Unless otherwise indicated, data are expressed as the number of participants.
| Clinical Factors | Training and Validation Cohort | Testing Cohort |
|---|---|---|
| Number of patients | 124 | 25 |
| Female | 47 (38%) | 12 (48%) |
| Age * | 58.3 ± 14.7 | 56.2 ± 16 |
| Cirrhosis with portal hypertension | 64 | 13 |
| Three most frequent lymphoma subtypes: | ||
| DLBCL | 13 | 6 |
| FL | 14 | 3 |
| TCL | 5 | 2 |
| Other ** | 30 | 2 |
* Data are expressed as mean ±standard deviation; ** Other hematologic diseases include the remaining subtypes as described above.